5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line. |
|
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status. |
|
Analyse systémique des sous-populations de cellules immunitaires et réseaux de communication intercellulaires dans les tumeurs du sein humaines. |
|
Une approche épistémologique du microenvironnement tumoral |
|
ATP-dependent chromatin remodeling and histone acetyltransferases in 5-FU cytotoxicity in Saccharomyces cerevisiae. |
|
BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder. |
|
The catalytic activities of DNA topoisomerase II are most closely associated with the DNA cleavage/religation steps. |
|
Catalytic topoisomerase II inhibitors in cancer therapy. |
|
Characterization of molecules derived from marine microorganisms, acting on metastatic breast cancer cells. |
|
Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. |
|
concept de cible en cancérologie |
|
Detection of IgG directed against a recombinant form of Epstein-Barr virus BALF0/1 protein in patients with nasopharyngeal carcinoma |
|
Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation |
|
DNA alkylation damage and autophagy induction. |
|
Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents. |
|
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies. |
|
Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation |
|
Epstein-Barr Virus BALF0 and BALF1 Modulate Autophagy |
|
FONCTIONS ET REGULATIONS DE L'ADN TOPOISOMERASE II HUMAINE AU COURS DES PHASES PRECOCES DE LA MITOSE |
|
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology. |
|
Integrative genomic study of hepatocellular carcinoma from Peru |
|
Intramolecular Aryne-Furan Cycloadditions for the Synthesis of Anticancer Naphthalimides |
|
The mesenchymal phenotype and the response to VEGF-targeted agents in colorectal cancer. |
|
Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A. |
|
Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. |
|
Modulation of Inflammation in Intestinal Epithelial and Immune Cells by N-Acyl Homoserine Lactones and their Synthetic Analogues |
|
Multifaceted Study on a Cytochalasin Scaffold: Lessons on Reactivity, Multidentate Catalysis, and Anticancer Properties |
|
The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators. |
|
PARPs and the DNA damage response |
|
Profili molecolari predittivi del potenziale metastatico del carcinoma uroteliale della vescica di stadio pt1 o superiore. |
|
Profils moléculaires prédictifs du potentiel métastatique du carcinome urothélial de la vessie de stade pT1 ou supérieur |
|
Réponse cellulaire induite par les dommages de l'ADN créés par les ecteinascidines, une classe unique de médicaments anticancéreux. |
|
Resistance mechanisms associated with altered intracellular distribution of anticancer agents. |
|
The role of the extracellular alarmins, HMGB1 and ATP, in colorectal cancer. |
|
Sphingosine kinase 1, transition épithélio-mésenchymateuse et résistance primaire aux inhibiteurs pharmacologiques de l'EGFR |
|
Synthèse et étude biochimique de l'effet d'un nouveau complexe de gallium sur l'invasion tumorale et l'activité inhibitrice des métalloprotéases matricielles in vitro. |
|
Systems Level Analysis of Immune Cell Subsets and Intercellular Communication Networks in Human Breast Cancer |
|
Talaroketals A and B, unusual bis(oxaphenalenone) spiro and fused ketals from the soil fungus Talaromyces stipitatus ATCC 10500. |
|
Unexpected talaroenamine derivatives and an undescribed polyester from the fungus Talaromyces stipitatus ATCC10500. |
|
What histone code for DNA repair? |
|